ARV treatment
Showing 1 - 25 of 610
Healthy Trial in Austin ([phenyl-14C]ARV-471, [oxoisoindolin-14C]ARV-471)
Recruiting
- Healthy
-
Austin, TexasPPD Phase I Clinic
Jun 29, 2023
Breast Cancer Trial in Shanghai (ARV-471)
Not yet recruiting
- Breast Cancer
-
Shanghai, ChinaCancer Hospital Chinese Academy of Medical Sciences
Feb 7, 2023
Breast Cancer Trial in Orange City (ARV-471 (PF-07850327), Palbociclib, Letrozole)
Recruiting
- Breast Cancer
- ARV-471 (PF-07850327)
- +2 more
-
Orange City, FloridaMid Florida Hematology and Oncology Center
Jun 8, 2023
Healthy Trial in New Haven (ARV-471, Rosuvastatin)
Recruiting
- Healthy
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Dec 29, 2022
Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation Trial (Sodium Fusidate, Placebo)
Not yet recruiting
- Cystic Fibrosis
- Cystic Fibrosis Pulmonary Exacerbation
- Sodium Fusidate
- Placebo
- (no location specified)
Dec 14, 2022
Melioidosis Trial in Udon Thani (Ceftazidime or meropenem, ARV-1801, Placebo)
Recruiting
- Melioidosis
- Ceftazidime or meropenem
- +2 more
-
Nai Muang, Thailand
- +4 more
Nov 29, 2022
Breast Cancer Trial in United States (ARV-471 in combination with Everolimus)
Not yet recruiting
- Breast Cancer
- ARV-471 in combination with Everolimus
-
San Diego, California
- +4 more
Aug 12, 2022
Breast Cancer Trial in Fort Collins, Greeley, Loveland (vepdegestrant, Samuraciclib)
Not yet recruiting
- Breast Cancer
-
Fort Collins, Colorado
- +3 more
Nov 4, 2023
Healthy Participants Trial in Brussels (Vepdegestrant, Carbamazepine)
Not yet recruiting
- Healthy Participants
-
Brussels, BelgiumPfizer Clinical Research Unit - Brussels
Aug 15, 2023
Prostate Cancer Metastatic Trial in United States (ARV-766)
Recruiting
- Prostate Cancer Metastatic
- ARV-766 Part A
- ARV-766 Part B
-
Duarte, California
- +20 more
Jan 31, 2023
Therapeutic Adherence and Compliance Trial in New York, Cape Town (Feedback on DBS Concentrations)
Completed
- Therapeutic Adherence and Compliance
- Feedback on DBS Concentrations
-
New York, New York
- +1 more
Dec 27, 2022
Breast Cancer Trial in United States (ARV-471, ARV-471 in combination with palbociclib (IBRANCE®))
Recruiting
- Breast Cancer
- ARV-471
- ARV-471 in combination with palbociclib (IBRANCE®)
-
Palo Alto, California
- +16 more
Jan 30, 2023
HPV Infection Trial (HPV vaccine, HPV testing, HAV vaccine)
Not yet recruiting
- HPV Infection
- HPV vaccine
- +2 more
- (no location specified)
Aug 2, 2022
Prostate Cancer Metastatic Trial in Worldwide (ARV-110 in Combination with Abiraterone)
Recruiting
- Prostate Cancer Metastatic
- ARV-110 in Combination with Abiraterone
-
Santa Monica, California
- +16 more
Jul 21, 2022
HIV Trial in San Diego (Digital Health Feedback System)
Active, not recruiting
- HIV
- Digital Health Feedback System
-
San Diego, California
- +1 more
Dec 21, 2022
HIV, Insulin Sensitivity, Diabetes Trial in Gaborone (Zidovudine, Nevirapine)
Completed
- HIV
- +2 more
-
Gaborone, BotswanaBotswana-Harvard AIDS Institute Partnership
Jul 18, 2022
HIV Trial in Lima (Atripla or Stribild)
Completed
- HIV
- Atripla or Stribild
-
Lima, PeruAsociación Civil Impacta Salud y Educación
Sep 16, 2022
ARv7 in Plasma of Advanced Metastatic Castrate Resistant
Active, not recruiting
- Metastatic Castrate Resistant Prostate Cancer
-
New Haven, ConnecticutYale University School of Medicine
Sep 29, 2021